Bohai Biomedical

Bohai Biomedical is a private China-based life sciences company in Shijiazhuang, Hebei, operating under the legal name 博海生物医药科技开发有限公司. Publicly available information indicates the company provides biomedical technology development and related research services, with capabilities described by third-party sources as spanning drug design, molecular biology, cell screening, and chemical analysis. The clearest disclosed external program is a 2022 feasibility-study collaboration with Asep Medical involving an anti-bacterial peptide oral-rinse candidate for dental biofilm infections in China. Chinese corporate registry data show the company remains active, while its registered business scope appears broader than drug development alone and includes biopharmaceutical R&D, technology services, and certain industrial-park/incubator activities. Overall, Bohai Biomedical appears to be a small, private health-related company with limited transparent pipeline disclosure rather than a broadly documented clinical-stage therapeutics developer.